in this issue
Chemical Week Magazine :: Business & Finance :: Europe/Mideast
Pfizer eyes AstraZeneca for reported $101 billion
6:42 AM MDT | April 25, 2014 | —Natasha Alperowicz
A recent UK press report says that Pfizer has made initial approaches to acquire AstraZeneca for £60 billion ($101 billion) in what would be the world’s largest pharmaceutical acquisition. The two companies have declined to comment on the report, which appeared in The Sunday Times. A deal between Pfizer and AstraZeneca would create one of the top 10 companies worldwide by market value. AstraZeneca has rejected Pfizer’s overtures, according to the report. AstraZeneca is in a transitional phase, with sales and earnings expected to decline for the...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be: